Durham, NC – According to filings with the U.S. Securities and Exchange Commission, Emvenio Research is raising $10,000,000.00 in new funding. Sources indicate as part of senior management President, Thad Wolfram played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Emvenio Research
We help organizations decentralize their clinical trials to better reach and recruit diverse, underserved, and high-risk communities. Emvenios network of skilled clinicians and virtual Principal Investigators enables us to provide robust care services via home visits, on-site support at medical facilities, virtual visits, and mobile sites. Our Mission: is to eliminate the barriers to clinical trials by engaging with people in their communities, where they live and work. Our Technology: is an enabled innovative network of Mobile Research Sites, At Home Visits and Virtual Visits with a unique blend of global DCT capabilities that can be deployed to better reach, recruit and retain diverse patient populations, while improving their clinical trial experience. Our Research: offers global DCT participant-centric approaches that provide flexibility, meet the most challenging clinical trial demands and provide convenience for patients and caregivers in a compliant manner. We are transforming how all stakeholders engage in, experience and deliver clinical research.

To learn more about Emvenio Research, visit http://emvenio.com/

Contact:
Thad Wolfram, President
617-947-6756
thad@emvenio.com
https://www.linkedin.com/in/thadwolfram/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved